Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
Speaker: Vincenza Pironti, PhD, MBA, Global SME, Sterile Drug Products.
– End to end service to make flawless the journey from development to commercialization of biologic product
– Expertise to drive the decisions in the right way to avoid rework and wasting of time
– Network offer includes different formats such as vials and pfs/pfc but also capacities with the possibility to develop the same product on different lines but with same level of quality